R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling

Su, Rui, Dong, Lei, Li, Chenying, Nachtergaele, Sigrid, Wunderlich, Mark, Qing, Ying, Deng, Xiaolan, Wang, Yungui, Weng, Xiaocheng, Hu, Chao, Yu, Mengxia, Skibbe, Jennifer, Dai, Qing, Zou, Dongling, Wu, Tong, Yu, Kangkang, Weng, Hengyou, Huang, Huilin, Ferchen, Kyle, Qin, Xi, Zhang, Bin, Qi, Jun, Sasaki, Atsuo T., Plas, David R., Bradner, James E., Wei, Minjie, Marcucci, Guido, Jiang, Xi, Mulloy, James C., Jin, Jie, He, Chuan, Chen, Jianjun·2018·Cell

DOI 10.1016/j.cell.2017.11.031

Cited by (1,000)

Items 801–900 of 1,000

A new perspective on hematological malignancies: m6A modification in immune microenvironment
Shiyu Yang, Liping Xu, Haihui Zhuang, Fenglin Li, Ying Lu · 2024 · Frontiers in Immunology
Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i
Makoto Harada, Jonathan Adam, Marcela Covic, Jianhong Ge, Stefan Brandmaier, Caroline Muschet, Jialing Huang, Siyu Han, Martina Rommel, Markus Rotter et al. · 2024 · Cardiovascular Diabetology
Role of RNA modifications in blood development and regeneration
Rajesh D. Gunage, Leonard Ira Zon · 2024 · Experimental Hematology
FTO Facilitates Cervical Cancer Malignancy Through Inducing m6A‐Demethylation of PIK3R3 mRNA
Bingxin Chen, Liming Wang, Xiaomin Li, Ci Ren, Chun Gao, Wencheng Ding, Hui Wang · 2024 · Cancer Medicine
NNMT-mediated N6-methyladenosine modification of NR4A3 mRNA facilitates lymphatic metastasis of gastric adenocarcinoma
Xiaoya Zhao, Linsen Bao, Yun Qian, Shimeng Zhou, Chen Chen, Zhuang Ma, Jiawen Xu, Mengmeng Li, Wenlu Niu, Wei Wang et al. · 2025 · Oncogene
Intricacies in the cross talk between metabolic enzymes, RNA, and protein translation
Yuan Lv, Muqddas Tariq, Xiangpeng Guo, Shahzina Kanwal, Miguel Angel Esteban · 2019 · Journal of Molecular Cell Biology
The old and the new: DNA and RNA methylation in normal and malignant hematopoiesis
Andrew A. Guirguis, Brian Liddicoat, Mark A. Dawson · 2020 · Experimental Hematology
Expression Status and Prognostic Value of m6A RNA Methylation Regulators in Lung Adenocarcinoma
Xiuhong Li, Zian Feng, Rui Wang, Jie Hu, Xiaodong He, Zuojun Shen · 2021 · Life
RNA m6A Alterations Induced by Biomineralization Nanoparticles: A Proof-of-Concept Study of Epitranscriptomics for Nanotoxicity Evaluation
Jinbin Pan, Jiaojiao Wang, Kun Fang, Wenjing Hou, Bing Li, Jie Zhao, Xinlong Ma · 2022 · Nanoscale Research Letters
Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review)
Tong Ye, Jiaxin Wang, Haiying Zhao, Guiping Zhao, Peng Li · 2022 · International Journal of Oncology
D-2-Hydroxyglutarate Inhibits Calcineurin Phosphatase Activity to Abolish NF-AT Activation and IL-2 Induction in Stimulated Lymphocytes
Faezeh Afsari, Thomas M. McIntyre · 2023 · The Journal of Immunology
N6-methyladenosine RNA modifications: a potential therapeutic target for AML
Rong Hu, Peiyun Liao, Binyan Xu, Yingqi Qiu, Honghao Zhang, Yuhua Li · 2023 · Annals of Hematology
Functions of N6-methyladenosine (m6A) RNA modifications in acute myeloid leukemia
Zehao Fang, Hanyi Ding, Jiongping Han, Leihua Fu, Jing Jin, Weiying Feng · 2024 · Journal of Leukocyte Biology
Specific patterns of H3K79 methylation influence genetic interaction of oncogenes in AML
Molly C. Kingsley, Hongbo Michael Xie, Bo-Rui Chen, Simone Stefanie Riedel, Taylor Pastuer, Madelyn K. Bollig, Tyler Shank, Clara Libbrecht, Sally P. Stabler, Aniruddha J. Deshpande et al. · 2020 · Blood Advances
The Impacts of Non-coding RNAs and N6-Methyladenosine on Cancer: Past, Present and Future
Zhao-Yuan Xu, Guohua Ji, Ying Cui, Xiaobo Cui · 2021 · Current Cancer Drug Targets
Dissecting the effects of METTL3 on alternative splicing in prostate cancer
Lin Wang, Ling Shi, Yonghao Liang, Judy Kin-Wing Ng, Chan Hoi Yin, Lingyi Wang, Jinpao Hou, Yiwei Wang, Cathy Sin‐Hang Fung, Peter Ka‐Fung Chiu et al. · 2023 · Frontiers in Oncology
Characterization of the nicotinamide adenine dinucleotides (NAD+ and NADP+) binding sites of the monomeric isocitrate dehydrogenases from Campylobacter species
Peng Wang, Xue-Fei Chen, Jing Chun Yang, Yunyun Pei, Mingjie Bian, Guoping Zhu · 2019 · Biochimie
Reviewing the IDH1 Mutation‐Mediated Mechanism of Drug Resistance and Revisiting Its Overcoming Strategies
Yifan Wang, Hailong Bai, Aixin Wang, Jun Zhao, Hui Guo, Yuping Tang, Yuwei Wang, Qinjian Xie · 2025 · Chemical Biology & Drug Design
K88 acetylation of FTO increases its RNA m6A demethylation and promotes tumorigenesis
Jing Li, Xinxin Zhang, Siyi Zhao, Ling Ran, Minmin Zhang, Shan Xie, Hui‐Fang Zhu, Guang‐Rong Yan · 2025 · Oncogene
Homoharringtonine Promotes FTO Degradation to Suppress LILRB4 ‐Mediated Immune Evasion in Acute Monocytic Leukaemia
Fangfang Huang, Xiang Luo, Mengyu Zhang, Le Jin, Wenxin Sun, Peihan Chen, Xiuli Hong, Chenyu Xu, Meizhi Jiang, Die Hu et al. · 2025 · Cell Proliferation
Molecular mechanisms and crop improvement potential of RNA N6-methyladenosine in plants
Diyi Fu, Huiyuan Wang, Bochen Jiang · 2025 · aBIOTECH
A novel derivative of rhein overcomes temozolomide resistance in glioblastoma by regulating SOX9 through m6A methylation
Li Cheng, Ting Wang, Rongbiao Pi, Pei‐Liang Zhao, Jingkao Chen · 2025 · Brain Research
Intracellular Mis-Localization of Modified RNA Molecules and Non-Coding RNAs: Facts from Hematologic Malignancies
Argiris S. Symeonidis, Argyri Chroni, Irene Dereki, Dionysios V. Chartoumpekis, Argyro Sgourou · 2025 · Current Issues in Molecular Biology
Activation of chaperone-mediated autophagy suppresses glioblastoma by promoting wild-type IDH1/isocitrate dehydrogenase 1 degradation
Wanjun Tang, Bo Chen, Philip Wing‐Lok Ho, Qi‐Yu Zheng, Cherry Tsz-Yee Ng, Zhiyuan Zhu, Gkk Leung, Karrie Mei Yee Kiang · 2025 · Autophagy
The m⁶A epitranscriptome: A regulatory nexus linking cellular senescence and oncogenesis
Yao Xu, Xin Zhou, Xiaoling Su, Wenxi Xie, Zhijie Huang, Shan Yu, Jinghua Tan, Jun He, Ji Zhang · 2026 · Ageing Research Reviews
Mitochondrial l-2-hydroxyglutarate is a physiological signalling metabolite
Ram Prosad Chakrabarty, Jonathan G. Van Vranken, Yuki Aoi, Taylor A. Poor, Gregory Scott McElroy, Karthik Vasan, Shimaa Hassan AbdelAziz Soliman, Marta Iwanaszko, Rogan A. Grant, Benjamin C. Howard et al. · 2026 · Nature
HGCLMDA: Predicting mRNA–Drug Sensitivity Associations via Hypergraph Contrastive Learning
Xiaowen Hu, Yihan Dong, Jiaxuan Zhang, Lei Deng · 2023 · Journal of Chemical Information and Modeling
Construction of a prognostic model for lung adenocarcinoma based on m6A/m5C/m1A genes
Hao Ding, Yuanyuan Teng, Ping Hui Gao, Qi Zhang, Mengdi Wang, Yi Yu, Yueping Fan, Li Zhu · 2023 · Human Molecular Genetics
Epigenetics and alternative splicing in cancer: old enemies, new perspectives
Madhura R. Pandkar, Sanjeev Shukla · 2024 · Biochemical Journal
Epigenetic Mechanisms in Osteoporosis: Exploring the Power of m6A RNA Modification
Shuo Tian, Yagang Song, Lin Guo, Zhao Hui, Ming Bai, Mingsan Miao · 2025 · Journal of Cellular and Molecular Medicine
YTHDC2 manipulates anti-tumoral macrophage polarization and predicts favorable outcomes in triple negative breast cancer
Hao Jin, Dongbo Zhang, Yufan Ma, Lanlan Meng, Songyin Huang, Hongjun Su, Jiannan Xu, Yandan Yao · 2025 · npj Precision Oncology
RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness
Huarong Chen, Yifei Wang, Hao Su, Xiaoting Zhang, Hongyan Chen, Jun Qing Yu · 2022 · Frontiers in Cell and Developmental Biology
Sensitive detection of fat mass and obesity-associated protein based on terminal deoxynucleotidyl transferase-mediated signal amplification
Xuemei Ma, Shi Liu, Haojie Xie, Deqi Kuang, Yetao Xu, Jiehua Ma, Jie Yang, Lizhou Sun · 2022 · Microchemical Journal
Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment
Yanjun Zhang, Lijuan Zhan, Jing Li, Xue Jiang, Yin Li · 2023 · Aging
Modifications of noncoding RNAs in cancer and their therapeutic implications
Le Zhang, Xiaonan Xu, Xiulan Su · 2023 · Cellular Signalling
RNA Modifications in Cancer Metabolism and Tumor Microenvironment
Ying Qing, Wu Dong, Xiaolan Deng, Jianjun Chen, Rui Jun Su · 2023 · Cancer treatment and research
Structure‐Activity Relationships of 2‐(Arylthio)benzoic Acid FTO Inhibitors
Chao Guo Yan, Qian Zhang, Pan Xiao, Xinyun Xie, Ming Li, Yuanlai Qiu, Liufa Wen, Xiaomin Song, Ze Dong, Cai‐Guang Yang · 2024 · Israel Journal of Chemistry
Signatures and Prognostic Values of N6-methyladenosine (m6A) - related Immune Genes in Bladder Cancer
Gaoteng Lin, Jianwei Zhang, Yuqi Wu, Shimiao Zhu, Gang Li · 2021 · Bioengineered
Quantitative Analysis of Oncometabolite 2-Hydroxyglutarate
Bi‐Feng Yuan · 2021 · Advances in experimental medicine and biology
Under explored epigenetic modulators: role in glioma chemotherapy
Yanhong Chen, Wenjing Zeng, Zhipeng Wen, Quan Cheng, Xiaoping Chen · 2018 · European Journal of Pharmacology
Exploring the connection between the Mitochondrial DNA and the Circadian Rhythm: Insights into Mitochondrial Biogenesis and its Dynamics
Sowmya Anand, Piyush Jagdish Balgote, Sivaraman Jayanthi · 2025 · Molecular Biology Reports
Functional nucleic acid-based biosensing for m6A-modifying enzyme activity monitoring
Zhiyan Chen, Xiyue Zhang, Huang Ping, Minghua Ge · 2025 · TrAC Trends in Analytical Chemistry
A Label‐Free Deoxyribozyme Sensor for m6A Demethylase Activity Detection†
Xiuyuan Wang, Shusheng Yu, Yuqiu He, Fuan Wang, Xiaoqing Liu · 2023 · Chinese Journal of Chemistry
In situ bioorthogonal-modulation of m 6 A RNA methylation in macrophages for efficient eradication of intracellular bacteria
Mengyu Sun, Jinsong Ren, Xiaogang Qu · 2024 · Chemical Science
RETRACTED: Investigating the mechanism of METTL16-dependent m6A modification regulating the SAMD11 protein signaling pathway to inhibit thyroid cancer phenotypes
Yingming Liu, Gang Wu, Xingru Tao, Jiayu Dong, Tiefeng Shi, Chenlei Shi · 2024 · International Journal of Biological Macromolecules · Retracted
The impact of epigenetic and epitranscriptomic modifications on Alzheimer’s disease: the mysteries of DNA, RNA, and histone methylation
Mingyuan Yao, Annan Liu, Jing Song, Liping Xing, Ying Huang, Honglin Li · 2025 · Brain Research
Comprehensive profiling of RNA modification-related genes identifies RNA m7G binding protein CBP20 as a therapeutic target for tumor growth inhibition
Yoonsung Cho, Sang Eun Lee, Jaeik Oh, Dongjun Jang, Seungjae Shin, Soo‐Jin Lee, Jiwon Kim, Yoojin Yang, Do‐Hee Kim, Hae Rim Jung et al. · 2025 · Experimental & Molecular Medicine
m6 A RNA Methylation Decreases Atherosclerotic Vulnerable Plaque Through Inducing T Cells
Chunmei Qi, Haoran Li, Yongshu Yu, Hao Ji, Hao Zhang, Lele Wang, Jingjing Jin, Qiang Zhou, Ya Hu, Chengmeng Zhang et al. · 2022 · Brazilian Journal of Cardiovascular Surgery
The emerging therapeutic target of dynamic and reversible N6-methyladenosine modification during cancer development
Shougeng Liu, Sihong Chen, Chengfang Tang, Yingxi Zhao, Wei Cui, Lina Jia, Lihui Wang · 2022 · Frontiers in Oncology
N6-methyladenosine in hematological malignancies: a concise review
Wan-Jie Wang, Tingting Xu, Jing Bao · 2022 · Current Opinion in Hematology
Albendazole induces an anti-tumor effect and potentiates PD-L1 blockade immunotherapy
Weinan Zhang, Zhiqiang He, Fucheng Liang, Jie Gong, Liuchang Tan, Juan Yang, Siji Song, Luoyingzi Xie, Yuangang Lu · 2023 · Journal of Cancer Research and Clinical Oncology
RNA Modifications in Cancer Stem Cell Biology
Jonas Cerneckis, Qi Cui, Wei Liu, Yanhong Shi · 2023 · Cancer treatment and research
Regulatory effects of natural products on N6-methyladenosine modification: A novel therapeutic strategy for cancer
Mao-mao, Jinjing Zhang, Yue-ping Xu, Minmin Shao, Meng‐Chuan Wang · 2024 · Drug Discovery Today
Epitranscriptomic orchestrations: Unveiling the regulatory paradigm of m6A, A‐to‐I editing, and m5C in breast cancer via long noncoding RNAs and microRNAs
Qinan Yin, Zhifeng Qu, Regina Mathew, Li Zeng, Zhe Du, Yun Xue, Dechun Liu, Xuewei Zheng · 2024 · Cell Biochemistry and Function
Complicated role of ALKBH5 in gastrointestinal cancer: an updated review
Weitong Shu, Qianying Huang, Rui Chen, Huatao Lan, Luxin Yu, Kai Cui, Wanjun He, Songshan Zhu, Mei Chen, Li Li et al. · 2024 · Cancer Cell International
HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma
Qiguang Li, Jie Liu, Chong Zeng, Daogang Qin, Zijian Zhang, Qiao‐Li Lv, Jingao Li, Wei Huang · 2024 · Cellular Oncology
Assembly of Dandelion-Like Nanoprobe for Sensitive Detection of N6-Methyladenosine Demethylase by Single-Molecule Counting
Yan Zhang, Xinyan Wang, Minghao Liu, Wenfei Li, Chaoyi Ren, Chenchen Li, Yukui Ma, Chun‐yang Zhang · 2024 · Analytical Chemistry
Enasidenib for the treatment of relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase 2 mutation
Maël Heiblig, Sabine Khalife‐Hachem, Christophe Willekens, Jean‐Baptiste Micol, Angélo Paci, Virginie Penard‐Lacronique, Stéphane de Botton · 2020 · Expert Review of Precision Medicine and Drug Development
The regulation of N6 ‐methyladenosine modification in PD‐L1 ‐induced anti‐tumor immunity
Wei Yu, Jinti Lin, Tao Yu, Jianan Lou, Chao Qian, Ankai Xu, Bing Liu, Huimin Tao, Libin Jin · 2023 · Immunology and Cell Biology
Comprehensive analysis of transcriptome-wide N6-methyladenosine methylomes in the Barrett's esophagus in rats
Ke Zou, Hui Dong, Mengmeng Li, Ying Zhang, Kai Zhang, Danlin Song, Chuanlian Chu · 2023 · Genomics
N6-methyladenosine methylation in ophthalmic diseases: From mechanisms to potential applications
Bingyan Li, Zicong Wang, Haixiang Zhou, Jingling Zou, Shigeo Yoshida, Yedi Zhou · 2023 · Heliyon
A prognostic signature based on genes associated with m6A/m5C/m1A/m7G modifications and its immunological characteristics in clear cell renal cell carcinoma
Wei He, Zixiang Cong, Chengtao Niu, Fajuan Cheng, Tinghai Yi, Zhongshun Yao, Yiming Zhang, Xue Feng Jiang, Xintong Sun, Zhihong Niu et al. · 2024 · Scientific Reports
Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications
Peilin Chen, Jianhang Hu, Xiaodong Han, Yabing Chen · 2022 · Molecular Biology Reports
Unmodified methodologies in target discovery for small molecule drugs: A rising star
Jiayue Tang, Meng Ou, Qiuling Zheng, Ya Ding · 2022 · Chinese Chemical Letters
N6-methyladenosine (m6A) regulator expression pattern correlates with the immune landscape in lung adenocarcinoma
Rongjun Wan, Lu Bai, Juan Jiang, Chengping Hu, Qiong Chen, Bingrong Zhao, Yan Zhang, Yuanyuan Li · 2022 · Gene
Epitranscriptomic Signatures in Neural Development and Disease
Shikha Sharma, Nibedita Lenka · 2021 · RNA technologies
The rs1421085 variant within FTO promotes but not inhibits thermogenesis and is potentially associated with human migration
Zhiyin Zhang, Na Chen, Ruixin Liu, Nan Yin, Yang He, Danjie Li, Muye Tong, Aibo Gao, Peng Lu, Huabing Li et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
IGF2BP2 Promotes Pancreatic Carcinoma Progression by Enhancing the Stability of B3GNT6 mRNA via m6A Methylation
Xiaofeng Xue, Pei Cao, Yufan Wu, Ding Sun, Weigang Zhang, Junyi Qiu, Zuxiong Tang, Lei Qin · 2021 · Research Square
N6-methyladenosine demethylase fat mass and obesity-associated protein suppresses hyperglycemia-induced endothelial cell injury by inhibiting reactive oxygen species formation via autophagy promotion
Di Xie, Kelaier Yang, Yang Xu, Yang Li, Chunnan Liu, Yanghong Dong, Jinyu Chi, Xinhua Yin · 2024 · Journal of Diabetes and its Complications
A Study of JUN’s Promoter Region and Its Regulators in Chickens
Ruihong Kong, Jieyao Shi, Ke Chang Xie, Han Wu, Wang Xu, Yani Zhang, Yingjie Wang · 2024 · Genes
IDH1 regulates human erythropoiesis by eliciting chromatin state reprogramming
Meng‐Jia Li, Hengchao Zhang, Xiuyun Wu, Mengqi Yu, Qianqian Yang, Lei Sun, Wei Li, Zhongxing Jiang, Fumin Xue, Ting Ting Wang et al. · 2024 · eLife
3D printing-biomimetic local stiff niche enhances glycolysis to boost PDAC cell stem-like phenotype via N6-methyladenosine-suppressed YAP1 mRNA decay
Di Wu, Xiaoqi Guan, Tao Yang, Jiashuai Yan, Biwen Zhu, Junchao Zhou, Yibing Guo, Yuhua Lu · 2025 · Materials Today Bio
Arsenic regulates ALKBH1 abundance and substrate specificity to promote translation and tumorigenicity
Emma Wilkinson, Yan‐Hong Cui, Zizhao Yang, Michelle Verghese, Seungwon Yang, Ming Sun, Houxiang Zhu, Jack Peterson, Jiangbo Wei, Yingming Zhao et al. · 2025 · Cell Reports
M6A methylation in tumor immune microenvironment: Multidimensional mechanism and targeted therapy strategies
Senxu Lu, Junxiu Liu, Shixin Chen, Binghao Li, Zhaoming Ye · 2025 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
m6A RNA Methylation Is Increased in Tumour Invasive Regions and Influences Invasive Capability and Chemotherapeutic Sensitivity in Adult Glioblastoma
Masar Radhi, Jonathan Rowlinson, Lauryn Walker, Simon Deacon, Helen Miranda Knight, Stuart James Smith · 2026 · International Journal of Molecular Sciences
YTHDF3 facilitates DNA damage response by recognizing METTL3-mediated m6A modification to promote chemotherapy resistance in glioblastoma
Meng Cheng, Ying Ki Pang, Rui Wang, Xu Chen, Chunyu Zhang, Yuntong Yang, Tongjie Ji, Yueyao Wu, Jingzhe Wang, Siyi Xu et al. · 2026 · Cancer Letters
RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition
Samuel E. Ross, Holly Holliday, Eyden Wang, Mahdi Zeraati, Maria Tsoli, David Simon Ziegler, Marcel E. Dinger · 2026 · Cell Death and Disease
Alkbh5 plays indispensable roles in maintaining self-renewal of hematopoietic stem cells
Bi-Jie Yang, Yuanyuan Liu, Feifei Xiao, Zhilong Liu, Zhe Chen, Zhigang Li, Chengfang Zhou, Mei Kuang, Yi Shu, Shan Liu et al. · 2023 · Open Medicine
Recent Advances of RNA m6A Modifications in Cancer Immunoediting and Immunotherapy
Shoubao Ma, Tasha Barr, Jianhua Yu · 2023 · Cancer treatment and research
Regulatory effect of N6-methyladenosine on tumor angiogenesis
Yuyan, Enwu Yuan · 2024 · Frontiers in Immunology
Modulation of host N6-methyladenosine modification by gut microbiota in colorectal cancer
Tian-Qi Jiang, Hao Wang, Wang-XinJun Cheng, Chuan Xie · 2024 · World Journal of Gastroenterology
Phosducin inhibits the cell proliferation and promotes the antitumor effect of temozolomide in glioma
Shibin Jiang, Lifang Zhu, Songshan Jiang · 2025 · Biochemical Pharmacology
Comprehensive Analysis of Differentially Expressed Profiles of mRNA 5-Methylcytosine Modification in Metabolic Dysfunction-Associated Steatotic Liver Disease
Yueying Yang, E Wang, Bing Zhou, Yan Lu, Xiaoying Ding, Yao Li · 2025 · Current Issues in Molecular Biology
The role of RNA methylation in glioma progression: mechanisms, diagnostic implications, and therapeutic value
Shao-Ze Zhang, Shaoyan Liu, Meng-Die Cheng, Yinfeng Zhang, Jiawei Tian · 2025 · Frontiers in Immunology
Epigenetic and epitranscriptomic regulation of cardiac metabolism in aging and disease
Junxi Liu, Mocun Yang, Boda Zhou · 2025 · The Journal of Cardiovascular Aging
Integrating transcriptomes and somatic mutations to identify RNA methylation regulators as a prognostic marker in hepatocellular carcinoma.
Yue Yan, Yun-Hai Luo, Daofeng Zheng, Tong Mu, Zhong-Jun Wu · 2020 · Hepatobiliary & Pancreatic Diseases International
Epitranscriptomics in myeloid malignancies
Li Han, Jianjun Chen, Rui Jun Su · 2022 · Blood Science
Modulation of DNA/RNA Methylation Signaling Mediating Metabolic Homeostasis in Cancer
Pallawi Choubey, Harshdeep Kaur, Kushagra Bansal · 2022 · Sub-cellular biochemistry/Subcellular biochemistry
N6-Methyladenosine-Modification-Related Ophthalmic Diseases and Potential Therapeutic Strategies
Xiaona Chen, Yi Xie, Qingyun Liu, Xiaoling Luo, Yali Gao · 2022 · Frontiers in Bioscience-Landmark
N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
Mingyang Ma, Tong Ye, Jiewei Wang, Haiying Zhao, Shutian Zhang, Peng Li, Guiping Zhao · 2022 · Diagnostics
ME2 Promotes Hepatocellular Carcinoma Cell Migration through Pyruvate
Yanting Yang, Zhenxi Zhang, Wei Li, Li Li, Ying Zhou, Wenjing Du · 2023 · Metabolites
Construction of an RNA modification-related gene predictive model associated with prognosis and immunity in gastric cancer
Airexiati Tuhongjiang, Feng Wang, Cheng-Rong Zhang, Sisi Pang, Yujiang Qu, Bo Feng, Gulimire Amuti · 2023 · BMC Bioinformatics
The implications of N6-methyladenosine (m6A) modification in esophageal carcinoma
Cheng He, Xiao Teng, Luming Wang, Miaoqi Ni, Linhai Zhu, Jiacong Liu, Wang Lv, Jian Hu · 2023 · Molecular Biology Reports
epidecodeR: a functional exploration tool for epigenetic and epitranscriptomic regulation
Kandarp Joshi, Dan O. Wang · 2024 · Briefings in Bioinformatics
The Noncanonical Functions of Metabolites in Tumor Progression
Siyang Wu, Yijun Qi, Weiwei Yang · 2024 · Metabolites
Trends and frontiers of RNA methylation in cancer over the past 10 years: a bibliometric and visual analysis
Bo-Na Liu, Xiaoli Gao, Ying Piao · 2024 · Frontiers in Genetics
Ivosidenib for the treatment of relapsed or refractory acute myeloid leukemia with an IDH1 mutation
Florence Pasquier, Claude Chahine, Christophe Marzac, Stéphane de Botton · 2020 · Expert Review of Precision Medicine and Drug Development
Analysis of the Expression Patterns and Clinical Relevance of m 6 A Regulators in 33 Cancer Types
Chundi Gao, Haiyang Yu, Huayao Li, Cun Liu, Xiaoran Ma, Jing Zhuang, Changgang Sun · 2021 · Future Oncology
m6A RNA modifications: Key regulators of normal and malignant hematopoiesis
Pia Sommerkamp, Jessie A. Brown, Myriam Luydmila Rachelle Haltalli, François Mercier, Ly Vu, Kamil R. Kranc · 2022 · Experimental Hematology
ADAR2-repressed RNA editing: a novel mechanism contributing to t (8:21) AML leukemogenesis
Mingrui Guo, Tim Hon Man Chan, Ömer An, Yangyang Song, Zi Hui Tan, Vanessa Hui En Ng, Xinang Cao, Wee Joo Chng, Motomi Osato, Henry He Yang et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)